Clinical Trial Update: A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults [Phase 3]

View source ↗

Summary

A Phase 3 trial update assessing long-term efficacy, safety, and persistence of immune response for a herpes zoster vaccine in older adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• GSK Herpes Zoster Vaccine (recombinant zoster vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Herpes Zoster | Phase 3 | Status: ACTIVE_NOT_RECRUITING